Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Value Market Research | PRODUCT CODE: 1967973

Cover Image

PUBLISHER: Value Market Research | PRODUCT CODE: 1967973

Global Genetic Toxicology Testing Market Size, Share, Trends & Growth Analysis Report 2026-2034

PUBLISHED:
PAGES: 163 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 3920
PDF & Excel (10-user License)
USD 4730
PDF & Excel (Corporate User License)
USD 7430

Add to Cart

The Genetic Toxicology Testing Market size is expected to reach USD 7.15 Billion in 2034 from USD 2.56 Billion (2025) growing at a CAGR of 12.11% during 2026-2034.

The Global Genetic Toxicology Testing Market is experiencing steady growth due to the increasing focus on drug safety, chemical risk assessment, and regulatory compliance across pharmaceutical and biotechnology industries. Genetic toxicology tests are essential for identifying mutagenic and carcinogenic risks before product approval. Rising R&D investments and the expansion of clinical pipelines are accelerating demand. Moreover, growing awareness about environmental toxins and food safety standards further supports market expansion globally.

Stringent regulations imposed by agencies such as the FDA and EMA are major growth drivers, compelling manufacturers to conduct comprehensive genotoxicity assessments. The growing adoption of in vitro testing methods and alternative non-animal models is improving efficiency and reducing ethical concerns. Technological advancements, including automated screening platforms and high-throughput testing systems, are enhancing accuracy and turnaround time. Additionally, increasing outsourcing of testing services to CROs is contributing to revenue growth.

In the coming years, the market is expected to witness strong momentum with the integration of artificial intelligence and predictive toxicology models. Emerging economies are investing in pharmaceutical manufacturing, creating new opportunities for service providers. Continuous innovation in biomarker identification and genomic technologies will further refine testing capabilities. As regulatory scrutiny intensifies and personalized medicine expands, the demand for reliable genetic toxicology testing solutions will continue to rise significantly.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

  • Reagents & Consumables
  • Assays Kit
  • Services

By Type

  • In Vitro
  • In Vivo

By Assay

  • Comet Assay
  • Micronucleus Assay
  • Chromosomal Aberration Test
  • Genetic Mutation Test
  • Others

By Application

  • Pharmaceutical & Biotechnology
  • Food Industry
  • Cosmetics Industry
  • Other

COMPANIES PROFILED

  • Laboratory Corporation of America Holdings, Eurofins Scientific, Thermo Fisher Scientific Inc, Charles River Laboratories, Jubilant Ingrevia Limited, Syngene International Limited, Gentronix, Inotiv, Creative Bioarray, MB Research Laboratories
  • We can customise the report as per your requirements.
Product Code: VMR11219924

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL GENETIC TOXICOLOGY TESTING MARKET: BY PRODUCT 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Product
  • 4.2. Reagents & Consumables Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Assays Kit Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL GENETIC TOXICOLOGY TESTING MARKET: BY TYPE 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Type
  • 5.2. In Vitro Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. In Vivo Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL GENETIC TOXICOLOGY TESTING MARKET: BY ASSAY 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast Assay
  • 6.2. Comet Assay Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Micronucleus Assay Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Chromosomal Aberration Test Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.5. Genetic Mutation Test Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL GENETIC TOXICOLOGY TESTING MARKET: BY APPLICATION 2022-2034 (USD MN)

  • 7.1. Market Analysis, Insights and Forecast Application
  • 7.2. Pharmaceutical & Biotechnology Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.3. Food Industry Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.4. Cosmetics Industry Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.5. Other Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL GENETIC TOXICOLOGY TESTING MARKET: BY REGION 2022-2034(USD MN)

  • 8.1. Regional Outlook
  • 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.2.1 By Product
    • 8.2.2 By Type
    • 8.2.3 By Assay
    • 8.2.4 By Application
    • 8.2.5 United States
    • 8.2.6 Canada
    • 8.2.7 Mexico
  • 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.3.1 By Product
    • 8.3.2 By Type
    • 8.3.3 By Assay
    • 8.3.4 By Application
    • 8.3.5 United Kingdom
    • 8.3.6 France
    • 8.3.7 Germany
    • 8.3.8 Italy
    • 8.3.9 Russia
    • 8.3.10 Rest Of Europe
  • 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.4.1 By Product
    • 8.4.2 By Type
    • 8.4.3 By Assay
    • 8.4.4 By Application
    • 8.4.5 India
    • 8.4.6 Japan
    • 8.4.7 South Korea
    • 8.4.8 Australia
    • 8.4.9 South East Asia
    • 8.4.10 Rest Of Asia Pacific
  • 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.5.1 By Product
    • 8.5.2 By Type
    • 8.5.3 By Assay
    • 8.5.4 By Application
    • 8.5.5 Brazil
    • 8.5.6 Argentina
    • 8.5.7 Peru
    • 8.5.8 Chile
    • 8.5.9 South East Asia
    • 8.5.10 Rest of Latin America
  • 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.6.1 By Product
    • 8.6.2 By Type
    • 8.6.3 By Assay
    • 8.6.4 By Application
    • 8.6.5 Saudi Arabia
    • 8.6.6 UAE
    • 8.6.7 Israel
    • 8.6.8 South Africa
    • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

  • 9.1. Recent Developments
  • 9.2. Company Categorization
  • 9.3. Supply Chain & Channel Partners (based on availability)
  • 9.4. Market Share & Positioning Analysis (based on availability)
  • 9.5. Vendor Landscape (based on availability)
  • 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL GENETIC TOXICOLOGY TESTING INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Company Profiles
    • 10.2.1 Laboratory Corporation Of America Holdings
    • 10.2.2 Eurofins Scientific
    • 10.2.3 Thermo Fisher Scientific Inc
    • 10.2.4 Charles River Laboratories
    • 10.2.5 Jubilant Ingrevia Limited
    • 10.2.6 Syngene International Limited
    • 10.2.7 Gentronix
    • 10.2.8 Inotiv
    • 10.2.9 Creative Bioarray
    • 10.2.10 MB Research Laboratories
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!